Amid good news on the vaccine trial-front, Australia must think more carefully about how a national roll-out would work.
The United Nations recently asked a group of experts across the world to recommend ways to persuade people to take a COVID-19 vaccine. Here is a summary of their suggestions.
COVID-19 vaccines are at risk of being undermined by vaccine hesitancy. Pharma must take steps to ensure transparency in data monitoring committees and trial data to build public trust in vaccines.
In the disturbing scenario of human-to-mink-to-human COVID-19 transmission, the virus may mutate in mink prior to re-infecting people. That possibility makes vaccine design even more crucial.
Inaction over the next few months could cost tens of thousands of lives. Here are things you should do now to stay safe and to stop the spread of the coronavirus.
Two pharma companies have announced early COVID-19 vaccine trial results with over 90 per cent effectiveness. What does that mean for getting back to normal?
Asking these four questions can help us identify good news when we see it, be more critical of news reports, or delay our judgement until we have more information.
There are two new COVID-19 vaccines that appear to be more than 90% effective. But what are these vaccines, and how are they different from those used previously?
A private market should have no place in the rollout of a COVID vaccine.
We will struggle to find a vaccine that works perfectly for people who need it most, despite what the headlines say is coming in 2021.
Whatever approach is taken, the vaccine roll-out has to be fair and efficient.
There's no guarantee future COVID-19 vaccines will work in the elderly. So we can consider vaccinating the young first to protect them. Here's what we need to work out first.
Watch two of Australia and New Zealand's top vaccine and virus experts answering questions about COVID-19. This was filmed at a Conversation reader event with Avid Reader bookshop.
The TRIPS waiver makes COVID-19 treatments more accessible globally by enabling manufacture and distribution of COVID-19 drugs and medical supplies that would normally be protected by patents.
Two more COVID-19 vaccines may now be on the cards for Australia, should they pass clinical trials. But, as with earlier vaccine deals, there are no guarantees.
So-called mRNA vaccines are among the frontrunners in the global race to design a COVID vaccine. But as a new technology, most nations, including Australia, lack the capacity to produce them at scale.
People who oppose vaccines often are dismissed as ignorant or naive. Failing to hear their concerns and address them may only be fueling vaccine resistance, however.
Any COVID-19 vaccine is likely to be given first to higher risk groups before it is given to children. But we still need vaccines that are safe and effective for them too.
Vaccines only work if enough people take them.
Details are sketchy. But it looks like people would still need to go through the legal system to get compensation. There are better ways.